Edwards Lifesciences EW Revenue Breakdown

NYSE EW
$103.90 -1.29 (-1.23%)
At close: Nov 19, 2026 · 4:00 PM EST
Quarterly revenue breakdowns for Edwards Lifesciences, quarters ended Mar 2010 to Sep 2026, as reported in its filings.
Quarterly history

Edwards Lifesciences Quarterly Revenue by Segment

Quarters Jun 2010–Sep 2026
Lines 4
Sep 2026 Total $1.72B

United States was Edwards Lifesciences’s largest segment in the Sep 2026 quarter, bringing in $1.01B of $1.72B (59%).

Edwards Lifesciences revenue by segment, quarters ended Jun 2010 to Sep 2026
Segment Jun 2010 Sep 2010 Mar 2012 Jun 2012 Sep 2012 Dec 2012 Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015 Jun 2015 Sep 2015 Dec 2015 Mar 2016 Jun 2016 Sep 2016 Dec 2016 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
United States $907.00M $937.60M $1.00B $1.01B
Europe $409.60M $442.60M $439.60M $414.60M
Rest Of World $165.50M $177.80M $201.50M $201.30M
Japan $87.50M $90.60M $96.40M $92.00M
Total $1.57B $1.65B $1.74B $1.72B
Totals include 6 discontinued lines from earlier reporting.
Quarterly history

Edwards Lifesciences Quarterly Revenue by Product & Service

Quarters Mar 2010–Sep 2026
Lines 3
Sep 2026 Total $1.72B

Transcatheter Aortic Valve Replacement was Edwards Lifesciences’s largest product and service line in the Sep 2026 quarter, bringing in $1.24B of $1.72B (72%).

Edwards Lifesciences revenue by product and service, quarters ended Mar 2010 to Sep 2026
Product and Service Mar 2010 Jun 2010 Sep 2010 Dec 2010 Mar 2011 Jun 2011 Sep 2011 Dec 2011 Mar 2012 Jun 2012 Sep 2012 Dec 2012 Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015 Jun 2015 Sep 2015 Dec 2015 Mar 2016 Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Transcatheter Aortic Valve Replacement $1.16B $1.20B $1.26B $1.24B
Surgical — $276.20M $284.10M $264.40M
Transcatheter Mitral & Tricuspid Therapies $155.70M $175.10M $198.60M $209.50M
Total $1.57B $1.65B $1.74B $1.72B
Totals include 8 discontinued lines from earlier reporting.

Edwards Lifesciences Revenue Breakdown API

Pull Edwards Lifesciences's revenue breakdown - every line it reports, for every period - into your own models, spreadsheets and apps with the Business Quant Segments API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/segments?series=Revenue&ticker=EW&dimension=Quarter&api_key=YOUR_API_KEY